Lazard Asset Management
CRNX icon

Lazard Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Lazard Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,612
Closed -$408K – 2413
2022
Q1 		$408K Buy
+18,612
New +$408K ﹤0.01% 1135